Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Using TMS to enhance behavioral therapy for Tourette Syndrome

Official title: Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

Run by West Virginia University · NCT05705999 · Data updated 2026-11-12

This study is testing if adding a brain stimulation treatment to behavioral therapy can help adults with Tourette Syndrome reduce their tics more effectively.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment20 (estimated)
SponsorWest Virginia University
Academic / other
Locations1 site (Morgantown, West Virginia)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedMarch 30, 2026
Study endsDecember 30, 2026
Registry record updatedJuly 18, 2025
Trial IDNCT05705999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with Tourette Syndrome and exhibiting moderate tic severity.

Probably not a fit

Patients with contraindications to rTMS, such as those with metallic implants or a history of seizures, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the effects of repetitive transcranial magnetic stimulation (rTMS) combined with comprehensive behavioral intervention for tics (CBIT) in adults with Tourette Syndrome. Participants with moderate tic severity will be randomly assigned to receive either active or sham rTMS targeting the supplementary motor area, followed by eight sessions of CBIT. The study aims to measure changes in tic frequency and severity, as well as neurophysiological changes, comparing outcomes between the two groups. The hypothesis is that rTMS will enhance the effectiveness of CBIT by positively influencing the SMA network.

Why it matters

Potential benefit: If successful, this approach could significantly improve tic management for patients with Tourette Syndrome.

How similar studies have gone: While this approach is innovative, similar studies using rTMS for neurological conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Diagnosis of Tourette Syndrome
* Moderate Tic Severity at baseline

Exclusion Criteria:

* Presence of metallic objects or neurostimulators in the brain
* Pregnancy
* History of active seizures or epilepsy
* Contraindications to receiving fMRI
* Inability to participate in CBIT due to other underlying cognitive or medical condition

Where it's running

  • Wvu Rni
    Morgantown, West Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.